Pathologic concordance of resected metastatic nonseminomatous germ cell tumors in the chest

J Thorac Cardiovasc Surg. 2021 Mar;161(3):856-868.e1. doi: 10.1016/j.jtcvs.2020.10.158. Epub 2020 Nov 30.

Abstract

Objective: Men with metastatic nonseminomatous germ cell tumors (NSGCTs) often present with residual chest tumors after chemotherapy. We examined the pathologic concordance of intrathoracic disease and outcomes based on the worst pathology of disease resected at first thoracic surgery.

Methods: A retrospective analysis was performed of consecutive patients undergoing thoracic resection for metastatic NSGCT in our institution between 2005 and 2018.

Results: Eighty-nine patients (all men) were included. The median age was 29 years (interquartile range [IQR], 23-35 years). Primary sites were testis (n = 84; 94.4%) and retroperitoneum (n = 5; 5.6%). Eighty-seven patients received chemotherapy before undergoing surgery. Nineteen patients (21.3%; group 1) had malignancy resected at first surgery (OR1), and the other 70 patients had benign disease at OR1 (78.7%; group 2). Concordant pathology between lungs was 85.2% in group 1 and 91% in group 2, and between lung and mediastinum was 50% in group 1 and 72.7% in group 2. Despite no teratoma at OR1, 3 patients (15.8%) in group 2 had resection of teratoma (n = 2) or malignancy (n = 1) at future surgery. After a mean follow-up of 65.5 months (IQR, 23.1-89.2 months) for group 1 and 47.7 months (IQR, 13.0-75.1 months) for group 2, overall survival was significantly worse for group 1 (68.4% vs 92.9%; P = .03).

Conclusions: The wide range of pathology resected in patients with intrathoracic NSGCT metastases requires careful decision making regarding treatment. Pathologic concordance between lungs is better than that between lung and mediastinum in patients with intrathoracic NSGCT metastases. Aggressive surgical management should be considered for all residual disease due to the low concordance between sites and the potential for excellent long-term survival even in patients with chemotherapy-refractory disease.

Keywords: lung metastases; nonseminomatous germ cell tumor; pathologic concordance; surgery; thoracic metastases.

Publication types

  • Comparative Study
  • Webcast

MeSH terms

  • Adult
  • Biopsy
  • Chemotherapy, Adjuvant
  • Clinical Decision-Making
  • Humans
  • Lung Neoplasms / mortality
  • Lung Neoplasms / secondary
  • Lung Neoplasms / surgery*
  • Male
  • Mediastinal Neoplasms / mortality
  • Mediastinal Neoplasms / secondary
  • Mediastinal Neoplasms / surgery*
  • Metastasectomy* / adverse effects
  • Metastasectomy* / mortality
  • Neoadjuvant Therapy
  • Neoplasm, Residual
  • Neoplasms, Germ Cell and Embryonal / mortality
  • Neoplasms, Germ Cell and Embryonal / secondary
  • Neoplasms, Germ Cell and Embryonal / surgery*
  • Patient Selection
  • Predictive Value of Tests
  • Retrospective Studies
  • Testicular Neoplasms / mortality
  • Testicular Neoplasms / pathology
  • Testicular Neoplasms / surgery*
  • Thoracic Surgical Procedures* / adverse effects
  • Thoracic Surgical Procedures* / mortality
  • Time Factors
  • Treatment Outcome
  • Young Adult

Supplementary concepts

  • Nonseminomatous germ cell tumor